Mismatch Repair Cancer Syndrome; Mmrcs

Description

Constitutional mismatch repair deficiency is a rare childhood cancer predisposition syndrome with 4 main tumor types: hematologic malignancies, brain/central nervous system tumors, colorectal tumors and multiple intestinal polyps, and other malignancies including embryonic tumors and rhabdomyosarcoma. Many patients show signs reminiscent of neurofibromatosis type I (NF1 ), particularly multiple cafe-au-lait macules (summary by Baas et al., 2013).'Turcot syndrome' classically refers to the combination of colorectal polyposis and primary tumors of the central nervous system (Hamilton et al., 1995). Trimbath et al. (2001) and Ostergaard et al. (2005) noted that the original definition of Turcot syndrome may be too restrictive, and suggested that the full manifestation of biallelic mutations in MMR genes includes the additional findings of early-onset hematologic malignancies and cafe-au-lait spots suggestive of neurofibromatosis type I.Several authors have observed 2 main groups of so-called 'Turcot syndrome.' Itoh and Ohsato (1985) noted that the colonic lesions seen in Turcot's original cases were characterized by autosomal recessive inheritance and multiple colonic polyps (up to 100), some of which exceeded 3 cm in diameter; the polyps frequently showed malignant transformation in the second and third decades of life. A distinct group of patients showed autosomal dominant inheritance of multiple small colonic polyps similar to classic FAP; the CNS tumor in these patients appeared to be an additional chance occurrence. Due to the similar phenotypes, FAP patients with brain tumors have sometimes been referred to in the past as having 'Turcot syndrome' (see, e.g., Lewis et al., 1983 and Lasser et al., 1994).Mastronardi et al. (1991) and Dupuis and Verellen-Dumoulin (1995) also identified 2 distinct syndromes comprising polyposis and CNS tumors. One shows autosomal recessive inheritance of polyps and gliomas, with CNS tumors as a primary feature; this group includes the original kindred of Turcot et al. (1959). The other group shows autosomal dominant FAP with CNS tumors, usually medulloblastomas, as an extracolonic manifestation. The colonic polyps in Turcot syndrome occur earlier, are less numerous and larger, and undergo malignant transformation earlier compared to those in FAP.Paraf et al. (1997) also proposed that Turcot syndrome, which they referred to as the 'brain tumor-polyposis (BTP) syndrome,' could be classified into 2 distinct entities. Patients with BTP syndrome type 1 have early onset of malignant gliomas and colorectal adenomas without polyposis; these are non-FAP cases. Neoplasms from these patients show DNA replication errors consistent with mutations in DNA mismatch repair genes. In contrast, BTP syndrome type 2 includes patients in FAP kindreds who develop CNS tumors. These patients have germline APC mutations which predispose to brain tumors. Risk analysis showed an increased incidence of medulloblastoma in FAP patients. By contrast, APC mutations were not found in sporadic glioma or medulloblastoma.Wimmer and Etzler (2008) provided a review of the mismatch cancer repair syndrome and suggested that the prevalence may be underestimated.

Clinical Features

Top most frequent phenotypes and symptoms related to Mismatch Repair Cancer Syndrome; Mmrcs

  • Milia
  • Neoplasm
  • Coma
  • Agenesis of corpus callosum
  • Carcinoma
  • Leukemia
  • Neutropenia
  • Sepsis
  • Lymphoma
  • Hypopigmentation of the skin
And another 31 symptoms. If you need more information about this disease we can help you.
Click here to know more about Mendelian.

Incidence and onset information

Not enough data available about incidence and published cases.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Mismatch Repair Cancer Syndrome; Mmrcs Recommended genes panels

Panel Name, Specifity and genes Tested/covered
HNPCC MSI & IHC Screening.

By Baylor Miraca Genetics Laboratories in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
MSH2 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MSH2
Specificity
100 %
Genes
25 %
Mismatch Repair Proteins Immunohistochemistry.

By Baylor Miraca Genetics Laboratories in United States.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
24 %
Genes
100 %
High Risk Hereditary Colorectal Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SMAD4, BMPR1A, STK11, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
34 %
Genes
100 %
Comprehensive Hereditary Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD51D, PMS1, ENG, BARD1, RAD51C, CDC73, PRKAR1A, PRF1, CEBPA, SBDS, PAX5, GATA2, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET , (...)

View the complete list with 41 more genes
Specificity
7 %
Genes
100 %
Turcot syndrome.

By Center for Human Genetics, Inc in United States.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Hereditary Non-Polyposis Colon Cancer.

By Center for Human Genetics, Inc in United States.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Comprehensive breast and ovarian cancer panel testing (18 genes).

By Molecular Genetics Laboratory North York General Hospital in Canada.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
23 %
Genes
100 %
MSH2 Deletion/Duplication.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MSH2
Specificity
100 %
Genes
25 %
MSH2 Sequencing and Deletion/Duplication.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MSH2
Specificity
100 %
Genes
25 %
Inherited Cancer Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

CDKN1B, BAP1, XRCC2, MITF, NF1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, CDKN2A, CDK4 , (...)

View the complete list with 29 more genes
Specificity
9 %
Genes
100 %
Inherited Colon Cancer.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

GREM1, POLD1, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
45 %
Genes
100 %
MLH1/MSH2 Comprehensive Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MLH1, MSH2
Specificity
100 %
Genes
50 %
VistaSeq Hereditary Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
Vistaseq Hereditary Cancer Panel Without BRCA.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
VistaSeq Brain/CNS/PNS Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

SMARCB1, NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, MEN1, RB1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
24 %
Genes
100 %
VistaSeq High Risk Colorectal Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
58 %
Genes
100 %
VistaSeq Renal Cell Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

MITF, GPC3, MET, FLCN, SDHD, TSC1, TSC2, SDHB, FH, SDHC, WT1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, VHL
Specificity
22 %
Genes
100 %
VistaSeq GYN Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
37 %
Genes
100 %
Tier 1: Hereditary Lymphoma and Immunodeficiency Panel.

By Genetic Services Laboratory University of Chicago in United States.

NPAT, POT1, TERF2IP, KLHDC8B, ACD, CHEK2, TP53, MLH1, MSH6, PMS2, MSH2
Specificity
37 %
Genes
100 %
Hereditary Gastric Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

PDGFRA, KIT, CTNNA1, SMAD4, BMPR1A, STK11, CDH1, SDHB, SDHC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
22 %
Genes
100 %
Comprehensive Hereditary Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, POLE, ETV6, IKZF1, POLD1, SRP72, BAP1, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, BRIP1, SMAD4, BMPR1A, MAX , (...)

View the complete list with 34 more genes
Specificity
8 %
Genes
100 %
Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Panel.

By Genetic Services Laboratory University of Chicago in United States.

RAD51, UBE2T, SAMD9L, SAMD9, NAF1, POT1, DNAJC21, ACD, CXCR4, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, ETV6, IKZF1, USB1 , (...)

View the complete list with 59 more genes
Specificity
6 %
Genes
100 %
Comprehensive Hereditary Breast/Ovarian Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
23 %
Genes
100 %
Hereditary nonpolyposis colon cancer.

By Institute of Human Genetics Universitätsmedizin Greifswald in Germany.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Germline mismatch repair gene mutation.

By Service de Génétique Gustave Roussy in France.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
MSH2 - Related Lynch Syndrome.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Cancer Panel - High Penetrance 16.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
25 %
Genes
100 %
MutS, E. COLI, HOMOLOG OF, 2; MSH2.

By Human Genetics Ruhr University in Germany.

MSH2
Specificity
100 %
Genes
25 %
Renal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

BAP1, MET, FLCN, SDHD, TSC1, TSC2, SDHB, FH, SDHC, TP53, PTEN, MLH1, MSH6, MSH2, VHL
Specificity
20 %
Genes
75 %
HNPCC/Lynch Syndrome Del/Dup.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Comprehensive Cancer Panel.

By GeneDx in United States.

AXIN2, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 9 more genes
Specificity
14 %
Genes
100 %
Oncology High/Moderate Risk Panel.

By GeneDx in United States.

RAD51D, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
100 %
Breast/Ovarian Cancer Panel.

By GeneDx in United States.

XRCC2, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
20 %
Genes
100 %
Colorectal Cancer Panel.

By GeneDx in United States.

AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
22 %
Genes
100 %
Endometrial Cancer Panel.

By GeneDx in United States.

POLD1, CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
34 %
Genes
100 %
Renal Cancer Panel.

By GeneDx in United States.

BAP1, MITF, MET, FLCN, SDHD, TSC1, TSC2, SDHB, FH, SDHC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, VHL
Specificity
23 %
Genes
100 %
MSH2 Exons 1-7 Inversion Analysis.

By GeneDx in United States.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Cancer Panel - Breast/Ovarian/Uterine26.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

ABRAXAS1, XRCC2, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 6 more genes
Specificity
16 %
Genes
100 %
Hereditary Cancer Panel - Renal19.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

MITF, CDC73, MET, FLCN, SDHD, TSC1, TSC2, SDHA, SDHB, FH, SDHC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, VHL
Specificity
22 %
Genes
100 %
Hereditary Cancer Panel - Neuro17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
24 %
Genes
100 %
Hereditary Cancer Panel - Pancreatic14.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
29 %
Genes
100 %
Hereditary Cancer Panel - Colorectal20.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

GALNT12, AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
20 %
Genes
100 %
Hereditary Cancer Panel - Breast/Ovarian17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
24 %
Genes
100 %
Lynch syndrome.

By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust in United Kingdom.

MLH1, MSH6, MSH2, EPCAM
Specificity
75 %
Genes
75 %
BrainTumorNext.

By Ambry Genetics in United States.

DICER1, POT1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, CDKN2A, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53 , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 14 more genes
Specificity
12 %
Genes
100 %
CustomNext: Cancer.

By Ambry Genetics in United States.

NTHL1, HOXB13, GALNT12, DICER1, POT1, AIP, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C , (...)

View the complete list with 48 more genes
Specificity
6 %
Genes
100 %
Lynch Syndrome Paired Testing.

By Ambry Genetics in United States.

NRAS, KRAS, BRAF, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
50 %
Genes
100 %
OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
ProstateNext.

By Ambry Genetics in United States.

HOXB13, RAD51D, CHEK2, PALB2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
29 %
Genes
100 %
PancNext.

By Ambry Genetics in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
31 %
Genes
100 %
RenalNext.

By Ambry Genetics in United States.

BAP1, MET, FLCN, SDHD, TSC1, TSC2, SDHA, SDHB, FH, SDHC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, VHL
Specificity
23 %
Genes
100 %
TumorNext-HRD+CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 14 more genes
Specificity
12 %
Genes
100 %
TumorNext-Lynch+CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 17 more genes
Specificity
11 %
Genes
100 %
TumorNext-HRD+OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
TumorNext-Lynch+OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, NRAS, KRAS, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
HNPCC/Lynch Syndrome Panel.

By Ambry Genetics in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
MLH1, MSH2, MSH6 gene sequence and deletion/duplication and EPCAM deletion/duplication reflex to PMS2 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
MLH1, MSH2, MSH6. NextGeneDx.Complete sequencing by NGS.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
MSH2. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Breast, Ovarian, and Endometrial Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

WRN, ITK, FANCA, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, MEN1, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
Hereditary Pancreatic Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

PRSS1, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
23 %
Genes
100 %
Hereditary Brain Tumor Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

SMARCB1, SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
24 %
Genes
100 %
Hereditary Kidney Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

BAP1, SMARCB1, CDC73, GPC3, MET, FLCN, SDHD, CDKN1C, TSC1, TSC2, SDHA, SDHB, FH, SDHC, WT1, PTEN, MLH1, MSH6, MSH2, VHL
Specificity
15 %
Genes
75 %
Hereditary nonpolyposis colorectal cancer (metilation analysis and deletions/duplications analysis of MLH1, MLH3, MSH2, MSH3, MSH6, PMS2 and MGMT by MS-MLPA).

By CGC Genetics in Portugal.

MSH3, MLH3, MLH1, MSH6, PMS2, MSH2
Specificity
67 %
Genes
100 %
Hereditary colorectal cancer.

By Laboratory of Genetics HUSLAB in Finland.

MLH3, POLE, POLD1, SMAD4, BMPR1A, STK11, MUTYH, MLH1, MSH6, PMS2, MSH2, APC
Specificity
34 %
Genes
100 %
MSH2-Related Lynch Syndrome.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

MSH2
Specificity
100 %
Genes
25 %
MLH1/MSH2/MSH6/PMS2/EPCAM Somatic Tumor MMR Sequencing and Deletion/Duplication Test.

By Impact Genetics Impact Genetics in Canada.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Colorectal Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLE, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
24 %
Genes
100 %
Pancreatic Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

PALLD, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
25 %
Genes
100 %
Lynch Syndrome via the MSH2 Exons 1-7 Inversion.

By PreventionGenetics PreventionGenetics in United States.

MSH2
Specificity
100 %
Genes
25 %
Lynch Syndrome via MSH2 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MSH2
Specificity
100 %
Genes
25 %
Lynch Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Hereditary Endometrial Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLD1, CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
34 %
Genes
100 %
Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DICER1, XRCC2, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
Prostate Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

HOXB13, RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
25 %
Genes
100 %
Neurofibromatosis and related disorders NGS panel.

By Connective Tissue Gene Tests in United States.

SPRED1, NF1, NF2, MLH1, MSH6, MSH2
Specificity
50 %
Genes
75 %
Neurofibromatosis and related disorders Comprehensive panel.

By Connective Tissue Gene Tests in United States.

SPRED1, NF1, NF2, MLH1, MSH6, MSH2
Specificity
50 %
Genes
75 %
Lynch Syndrome gene sequencing and deletion/dupliction analysis.

By Molecular Diagnostics Laboratory University Health Network in Canada.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Lynch Syndrome.

By MGZ Medical Genetics Center in Germany.

KRAS, BRAF, MLH1, MSH6, PMS2, MSH2
Specificity
67 %
Genes
100 %
Colorectal Cancer.

By MGZ Medical Genetics Center in Germany.

BUB1B, PMS1, SMAD4, BMPR1A, CHEK2, MET, STK11, NBN, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC
Specificity
25 %
Genes
100 %
Ovarian Cancer – Basic Diagnostics.

By MGZ Medical Genetics Center in Germany.

RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
31 %
Genes
100 %
Hnpcc Deep Intronic.

By MGZ Medical Genetics Center in Germany.

MSH3, MLH3, PMS1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
50 %
Genes
100 %
Breast Cancer.

By MGZ Medical Genetics Center in Germany.

CEP57, BUB1B, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, NF1, RAD51D, RAD51C, BRIP1, CHEK2, SDHD, STK11, CDH1 , (...)

View the complete list with 17 more genes
Specificity
11 %
Genes
100 %
MSH2-Related Lynch Syndrome.

By Bioscientia GmbH Center for Human Genetics in Germany.

MSH2
Specificity
100 %
Genes
25 %
Hereditary non-polyposis Colon Cancer.

By Synlab MVZ Humane Genetik München Synlab MVZ Humane Genetik München in Germany.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Prostate cancer panel.

By Centogene AG - the Rare Disease Company in Germany.

HOXB13, CHEK2, NBN, TP53, PTEN, MLH1, MSH6, MSH2, BRCA2, BRCA1
Specificity
30 %
Genes
75 %
CentoColon extended panel.

By Centogene AG - the Rare Disease Company in Germany.

NTHL1, POLE, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
24 %
Genes
100 %
MMR genes methylation analysis.

By Centogene AG - the Rare Disease Company in Germany.

MSH3, MLH3, MGMT, MLH1, MSH6, PMS2, MSH2
Specificity
58 %
Genes
100 %
Renal cell carcinoma Panel.

By CeGaT GmbH in Germany.

BAP1, MITF, MET, FLCN, SDHD, PALB2, TSC1, TSC2, SDHA, SDHB, FH, SDHC, HNF1B, SDHAF2, WT1, HNF1A, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
100 %
Test for MSH2-Related Lynch Syndrome.

By All Wales Genetics Laboratory Institute of Medical Genetics in United Kingdom.

MSH2
Specificity
100 %
Genes
25 %
MSH2-Related Lynch Syndrome.

By ProntoLab - MLPA Lab Pronto Diagnostics Ltd. in Israel.

MSH2
Specificity
100 %
Genes
25 %
Breast and Ovarian Cancer.

By Asper Biogene Asper Biogene LLC in Estonia.

CHD1, RAD51, XRCC2, FANCD2, FANCE, FANCF, FANCG, FANCA, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, PALB2, NBN, MRE11, ATM, KRAS, FANCC , (...)

View the complete list with 9 more genes
Specificity
11 %
Genes
75 %
Ashkenazi Jewish diseases.

By Asper Biogene Asper Biogene LLC in Estonia.

F11, MEFV, CYP21A2, LRRK2, TOR1A, TMEM216, ABCC8, MCOLN1, SERPINA1, NEB, FKTN, SMN1, LDLR, GJB2, BLM, GBA, FANCC, CFTR, ELP1, ASPA , (...)

View the complete list with 17 more genes
Specificity
6 %
Genes
50 %
Lynch Syndrome.

By Asper Biogene Asper Biogene LLC in Estonia.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Hereditary Non-Polyposis Colon Cancer (HNPCC),MSH2 sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

MSH2
Specificity
100 %
Genes
25 %
MSH2-Related Lynch Syndrome.

By Clinical Genomics Maastricht University Medical Centre in Netherlands.

MSH2
Specificity
100 %
Genes
25 %
Lynch syndrome/HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM).

By Center for Human Genetics Cliniques Universitaires Saint Luc in Belgium.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
MSH2 Gene Sequencing.

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

MSH2
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis, 1.

By Praxis fuer Humangenetik Wien in Austria.

MSH2
Specificity
100 %
Genes
25 %
Lynch Syndrome.

By Department of Clinical Genetics St. Elisabeth Cancer Institute in Slovakia.

MSH2
Specificity
100 %
Genes
25 %
Inherited Cancer Screen.

By Counsyl in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, SDHA , (...)

View the complete list with 16 more genes
Specificity
12 %
Genes
100 %
qCancer Risk.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53 , (...)

View the complete list with 10 more genes
Specificity
14 %
Genes
100 %
qCancer Risk Expanded.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, MITF, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1 , (...)

View the complete list with 25 more genes
Specificity
9 %
Genes
100 %
qCancer Gine.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
100 %
qCancer Colorrectal.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
24 %
Genes
100 %
Colorectal cancer, hereditary nonpolyposis, 1.

By MedGene in Slovakia.

MSH2
Specificity
100 %
Genes
25 %
Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI).

By Invitae in United States.

DICER1, AXIN2, POLE, PDGFRA, GREM1, POLD1, KIT, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, STK11 , (...)

View the complete list with 22 more genes
Specificity
10 %
Genes
100 %
Invitae Gastric Cancer Panel.

By Invitae in United States.

PDGFRA, KIT, NF1, SMAD4, BMPR1A, SDHD, STK11, CDH1, SDHA, SDHB, SDHC, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
23 %
Genes
100 %
Invitae Multi-Cancer Panel.

By Invitae in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, KIT, SMARCB1, SMARCA4, SMARCE1, TERT, TERC, MITF , (...)

View the complete list with 60 more genes
Specificity
5 %
Genes
100 %
Invitae Breast and Gyn Cancers Guidelines-Based Panel.

By Invitae in United States.

NF1, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
22 %
Genes
100 %
Invitae Pediatric Nervous System/Brain Tumors Panel.

By Invitae in United States.

DICER1, SMARCB1, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, MEN1, RB1, TP53, PTEN, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
100 %
Invitae Pediatric Hematologic Malignancies Panel.

By Invitae in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
25 %
Genes
100 %
Invitae Myelodysplastic Syndrome/Leukemia Panel.

By Invitae in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
25 %
Genes
100 %
Invitae Lynch Syndrome Panel.

By Invitae in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Invitae Pancreatic Cancer Panel.

By Invitae in United States.

NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
20 %
Genes
100 %
Invitae Breast and Gyn Cancers Panel.

By Invitae in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
100 %
Invitae Colorectal Cancer Guidelines-Based Panel.

By Invitae in United States.

SMAD4, BMPR1A, STK11, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
34 %
Genes
100 %
ONCOLOGY, PANEL.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

POLH, XPC, HOXB13, XPA, ERCC5, AIP, ELANE, PDGFRA, GREM1, ERCC4, CDKN1B, XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA , (...)

View the complete list with 60 more genes
Specificity
5 %
Genes
100 %
COLON, BREAST AND OVARIAN CANCER.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MLH3, AXIN2, XRCC2, NF1, RAD51D, PMS1, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, KRAS , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
100 %
Lynch Syndrome: MSH2 Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MSH2
Specificity
100 %
Genes
25 %
Lynch Syndrome: MLH1, MSH2, and MSH6 Full Gene Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Lynch Syndrome: MLH1, MSH2, and MSH6 Gene Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Hereditary Cancer Syndrome: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
7 %
Genes
100 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
25 %
Genes
100 %
Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

XRCC2, SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
100 %
Gastrointestinal and Colorectal Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
22 %
Genes
100 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
20 %
Genes
75 %
Gastrointestinal and Colorectal Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
16 %
Genes
75 %
Hereditary Cancer Syndrome: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
6 %
Genes
75 %
Lynch Syndrome (HNPCC) Panel.

By Fulgent Genetics Fulgent Genetics in United States.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Pancreatic Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BAP1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
29 %
Genes
100 %
MSH2 Full Gene Sequencing.

By Fulgent Genetics Fulgent Genetics in United States.

MSH2
Specificity
100 %
Genes
25 %
MSH2.

By Fulgent Genetics Fulgent Genetics in United States.

MSH2
Specificity
100 %
Genes
25 %
Focus Cancer Panel - 40 Genes.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51, AXIN2, POLE, BAP1, KIT, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 20 more genes
Specificity
10 %
Genes
100 %
Endometrial Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

POLD1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
40 %
Genes
100 %
Ovarian Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51D, BARD1, RAD51C, BRIP1, STK11, NBN, MRE11, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
25 %
Genes
100 %
Nervous System / Brain Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ATM, ALK, TSC1, TSC2, HRAS, MEN1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
Pancreatic Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

NF1, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TSC1, TSC2, FANCC, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL , (...)

View the complete list with 2 more genes
Specificity
19 %
Genes
100 %
Colorectal Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

MLH3, GALNT12, AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
22 %
Genes
100 %
Ovarian Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, STK11, NBN, MRE11, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
24 %
Genes
100 %
Prostate Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

HOXB13, CHEK2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
37 %
Genes
100 %
Sarcoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
16 %
Genes
100 %
Renal / Urinary Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DIS3L2, DICER1, BAP1, SMARCB1, SMARCA4, MITF, CDC73, GPC3, MET, FLCN, SDHD, CDKN1C, TSC1, TSC2, SDHA, SDHB, FH, SDHC, WT1, TP53 , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
MyVantage(TM) Hereditary Comprehensive Cancer Panel.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, SDHB , (...)

View the complete list with 14 more genes
Specificity
12 %
Genes
100 %
Lynch Syndrome Panel.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Hereditary Leukemia Panel.

By Blueprint Genetics in Finland.

DDX41, SAMD9L, ETV6, IKZF1, SRP72, FANCA, TERT, TERC, DKC1, NF1, CEBPA, SBDS, PAX5, GATA2, CDKN2A, NBN, ATM, CBL, MAP2K2, RIT1 , (...)

View the complete list with 19 more genes
Specificity
11 %
Genes
100 %
Comprehensive Hereditary Cancer Panel.

By Blueprint Genetics in Finland.

REST, PPM1D, EXO1, CD70, CEP57, ERCC1, MLH3, DDB2, DIS3L2, NTHL1, HOXB13, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, DDX41, SAMD9L , (...)

View the complete list with 126 more genes
Specificity
3 %
Genes
100 %
Hereditary Colorectal Cancer Panel.

By Blueprint Genetics in Finland.

NTHL1, AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, STK11, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
23 %
Genes
100 %
Hereditary Pancreatic Cancer Panel.

By Blueprint Genetics in Finland.

BUB1B, NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, FANCC, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL , (...)

View the complete list with 2 more genes
Specificity
19 %
Genes
100 %
Comprehensive Hematology Panel.

By Blueprint Genetics in Finland.

ARPC1B, MRTFA, GINS1, DCLRE1B, ERCC6L2, MTHFD1, AP3D1, SMARCD2, WDR1, LMAN1, MCFD2, RPS29, MECOM, TMPRSS6, F13B, SERPINC1, DHFR, F13A1, TF, F12 , (...)

View the complete list with 219 more genes
Specificity
2 %
Genes
100 %
Bone Marrow Failure Syndrome Panel.

By Blueprint Genetics in Finland.

ERCC6L2, SMARCD2, RPS29, DDX41, SAMD9L, SAMD9, DNAJC21, PGM3, ACD, JAGN1, WIPF1, CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, VPS45, G6PC3, RPL15, ITK , (...)

View the complete list with 102 more genes
Specificity
4 %
Genes
100 %
Hereditary Gastrointestinal Cancer Panel.

By Blueprint Genetics in Finland.

NTHL1, RHBDF2, BUB1B, AXIN2, POLE, PDGFRA, GREM1, POLD1, KIT, SMARCB1, NF1, SMAD4, BMPR1A, SDHD, CDKN2A, STK11, CDH1, PALB2, ATM, TSC1 , (...)

View the complete list with 19 more genes
Specificity
11 %
Genes
100 %
Hereditary Breast and Gynecological Cancer Panel.

By Blueprint Genetics in Finland.

DICER1, XRCC2, FANCM, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, BLM, TP53, PTEN , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
Lynch syndrome type 1.

By Bioarray in Spain.

MSH2
Specificity
100 %
Genes
25 %
Hereditary nonpolyposis colorectal cancer type I.

By Bioarray in Spain.

MSH2
Specificity
100 %
Genes
25 %
iGene Cancer Panel.

By ApolloGen, Inc. in United States.

NF1, RAD51C, BRIP1, SMAD4, BMPR1A, CDKN2A, STK11, CDH1, PALB2, PTCH1, NBN, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
FoundationOne® Heme.

By Foundation Medicine, Inc. in United States.

TRAF5, PIM1, PRDM1, HIST1H2AG, HIST1H3B, HIST1H1C, HDAC1, GTSE1, HIST1H1D, HIST1H2BK, HIST1H2BO, HIST1H2BC, HIST1H2AC, HIST1H2AM, HIST1H1E, HIST1H2AL, HDAC7, HIST1H2BJ, INPP5D, IKZF2 , (...)

View the complete list with 385 more genes
Specificity
1 %
Genes
75 %
Hereditary Colon and Endometrial Cancer-ColoNGS.

By GeneKor MSA in Greece.

MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
58 %
Genes
100 %
Hereditary Breast and Ovarian Cancer 26 Gene Panel.

By Veritas Genetics Veritas Genetics in United States.

ABRAXAS1, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, MEN1, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
MSH2 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Cancer Comprehensive Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TP53BP1, KLLN, CHEK1, GEN1, MYH15, MYH1, MYH13, MYH4, PPM1D, HOXB13, MYH10, GALNT12, RAD51, AKT1, POLE, ABRAXAS1, ETV6, GREM1, POLD1, PIK3CA , (...)

View the complete list with 53 more genes
Specificity
6 %
Genes
100 %
NeoTYPE® Discovery Profile for Solid Tumors.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

IKBKE, INPP4B, HSP90AA1, LRP1B, BCL2L2, AURKB, LMO1, ARFRP1, MDM4, MAP2K4, MCL1, EMSY, CHEK1, PBRM1, DAXX, PDCD1LG2, EPHB1, EPHA3, DOT1L, EPHA5 , (...)

View the complete list with 295 more genes
Specificity
2 %
Genes
100 %
Caris MI TumorSeek 592-Gene NGS Panel.

By Caris Life Sciences in United States.

ETV1, BCL3, SET, ELL, BTG1, ADGRA2, ACSL3, AFF1, ACSL6, ACKR3, RABEP1, PSIP1, RANBP17, RAD51B, RPL22, SDC4, SH3GL1, REL, SLC45A3, SYK , (...)

View the complete list with 571 more genes
Specificity
1 %
Genes
100 %
OmniSeq Comprehensive.

By OmniSeq, Inc. in United States.

NKX2-8, RHOA, BCL2L1, ETV4, ETV1, GAS6, RPS6KB1, RHEB, SPOP, TIAF1, XPO1, ZNF217, JAK1, KNSTRN, IFITM1, APEX1, ATP11B, MDM4, BCL9, BIRC2 , (...)

View the complete list with 124 more genes
Specificity
2 %
Genes
50 %
Hereditary Non-Polyposis Colon Cancer, Sequencing MSH2 Gene.

By Reference Laboratory Genetics in Spain.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer, Deletions-Duplications (MLPA) MSH2 Gene.

By Reference Laboratory Genetics in Spain.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Colon Cancer , Panel Massive Sequencing (NGS) 14 Genes.

By Reference Laboratory Genetics in Spain.

MSH3, ENG, SMAD4, BMPR1A, FLCN, STK11, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
29 %
Genes
100 %
Breast and Ovarian Hereditary Cancer , Panel Massive Sequencing (NGS) 20 Genes.

By Reference Laboratory Genetics in Spain.

NF1, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
20 %
Genes
100 %
Hereditary Renal Cancer , Panel Massive Sequencing (NGS) 21 Genes.

By Reference Laboratory Genetics in Spain.

DIS3L2, BAP1, MITF, MET, FLCN, SDHD, TSC1, TSC2, SDHB, FH, HNF1B, WT1, HNF1A, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
20 %
Genes
100 %
Uterine Cancer , Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
67 %
Genes
100 %
Hereditary Sarcoma (Susceptibility to) , Panel Massive Sequencing (NGS) 25 Genes.

By Reference Laboratory Genetics in Spain.

DICER1, WRN, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHB, FH, SDHC, SDHAF2, RB1, TP53, RECQL4, MLH1 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
genTrue.

By True Health Diagnostics in United States.

POLE, POLD1, RAD51D, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 6 more genes
Specificity
16 %
Genes
100 %
Phosphorus Colorectal Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
23 %
Genes
100 %
Phosphorus Leukemia including Fanconi Anemia Genes Panel.

By Phosphorus Diagnostics LLC in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, TERT, TERC, DKC1, FANCB, NF1, RAD51C, CEBPA, GATA2, BRIP1 , (...)

View the complete list with 15 more genes
Specificity
12 %
Genes
100 %
Phosphorus Prostate Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

HOXB13, RAD51D, CHEK2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
31 %
Genes
100 %
Tempus xT assay.

By Tempus Labs, Inc. in United States.

HLA-DRB5, HLA-C, PPP6C, ZNRF3, FOXQ1, TBC1D12, WEE1, YEATS4, POU2F2, C8orf34, SEMA3C, PDPK1, HLA-G, LAG3, CCDC6, MEF2B, AURKA, TOP1, P2RY8, FGF4 , (...)

View the complete list with 571 more genes
Specificity
1 %
Genes
100 %
Tempus xO assay.

By Tempus Labs, Inc. in United States.

SETD6, PIM3, MAP3K10, PDGFA, MAP3K11, PAK2, KHSRP, WASL, CASC11, GLIS1, NRG2, SOX21, SMARCC1, CUL4A, UTY, WNT9A, TEF, CHIC1, TRIM28, CDK11B , (...)

View the complete list with 1693 more genes
Specificity
1 %
Genes
100 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
25 %
Genes
100 %
Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

XRCC2, SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
100 %
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RAD51B, EHBP1, POU6F2, EPHB2, MSMB, ASCC1, MSR1, XRCC3, PTCH2, PALLD, MLH3, DDB2, DIS3L2, MTAP, POLH, UROD, TMC8, TMC6, PDE11A, XPC , (...)

View the complete list with 123 more genes
Specificity
3 %
Genes
100 %
Gastrointestinal and Colorectal Cancer: gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
22 %
Genes
100 %
Gastrointestinal and Colorectal Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
16 %
Genes
75 %
High Risk Colorectal Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC
Specificity
20 %
Genes
75 %
Lynch Syndrome: Microsatellite Instability.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Lynch Syndrome: MLH1, MSH2, MSH6, and PMS2 Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Lynch Syndrome: MSH2 Gene Sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MSH2
Specificity
100 %
Genes
25 %
Lynch Syndrome: MLH1, MSH2, and MSH6 Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Lynch Syndrome: MLH1, MSH2, and MSH6 Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Lynch Syndrome: MLH1, MSH2, MSH6, and EPCAM Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1, MSH6, MSH2, EPCAM
Specificity
75 %
Genes
75 %
Hereditary Cancer Syndrome: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
7 %
Genes
100 %
Hereditary Cancer Syndrome: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
6 %
Genes
75 %
MSH2 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MSH2
Specificity
100 %
Genes
25 %
MSH2 Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MSH2
Specificity
100 %
Genes
25 %
MSH2 Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
24 %
Genes
100 %
Hereditary Pancreatic Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD50, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
24 %
Genes
100 %
Hereditary Colorectal/Gastrointestinal Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

PMS1, ENG, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 2 more genes
Specificity
19 %
Genes
100 %
Lynch syndrome/HNPCC (MLH1, MSH2, MSH6, PMS2, TACSTD1).

By Center for Human Genetics, Inc in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) Mutation, Deletion/Duplication Analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
MSH2 Sequence Analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

MSH2
Specificity
100 %
Genes
25 %
MSH2 Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MSH2
Specificity
100 %
Genes
25 %
MLH1, MSH2, and MSH6 Sequencing Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Inherited Ovarian Cancer.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
58 %
Genes
100 %
Hereditary Nonpolyposis Colorectal Cancer (HNPCC): MSH2 (Known Mutation).

By Molecular Diagnostic Laboratory LabCorp in United States.

MSH2
Specificity
100 %
Genes
25 %
MLH1/MSH2/MSH6 Comprehensive Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
MLH1/MSH2/MSH6/PMS2 Comprehensive Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
MSH2 Comprehensive Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MSH2
Specificity
100 %
Genes
25 %
MSH2 Deletion/Duplication Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MSH2
Specificity
100 %
Genes
25 %
VisaSeq Breast and GYN Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
VistaSeq Pancreatic Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
29 %
Genes
100 %
VistaSeq Colorectal Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

AXIN2, POLE, POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 2 more genes
Specificity
19 %
Genes
100 %
myRisk Hereditary Cancer.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH , (...)

View the complete list with 8 more genes
Specificity
15 %
Genes
100 %
COLARIS Plus.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
MSH2-Related Lynch syndrome.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

MSH2
Specificity
100 %
Genes
25 %
Tier 2: Familial Myelodysplastic Syndrome/Acute Leukemia (MDS/AL) Panel.

By Genetic Services Laboratory University of Chicago in United States.

NF1, CHEK2, ATM, CBL, PTPN11, BLM, TP53, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
31 %
Genes
100 %
Lynch Syndrome Panel.

By Genetic Services Laboratory University of Chicago in United States.

POLE, POLD1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
58 %
Genes
100 %
Hereditary Leukemia and Breast Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, ETV6, IKZF1, SRP72, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, CHEK2, CDH1, PALB2, NBN, ATM, CBL, PTPN11 , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
100 %
Hereditary Colorectal Cancer High Risk Panel.

By Genetic Services Laboratory University of Chicago in United States.

POLE, POLD1, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
45 %
Genes
100 %
Comprehensive Hereditary Colorectal Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

GALNT12, BUB1B, AXIN2, POLE, GREM1, POLD1, ENG, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
20 %
Genes
100 %
MSH2-Related Lynch Syndrome.

By Molecular Genetics Rabin Medical Center in Israel.

MSH2
Specificity
100 %
Genes
25 %
MSH2.

By Institute for Human Genetics University Clinic Freiburg in Germany.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Cancer Panel Comprehensive.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

POLE, GREM1, POLD1, CTNNA1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, SDHB, TP53 , (...)

View the complete list with 10 more genes
Specificity
14 %
Genes
100 %
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 20 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, MEN1, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, BRCA2, BRCA1
Specificity
15 %
Genes
75 %
Cancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

CDKN1B, BAP1, SMARCB1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1, SUFU, PALB2 , (...)

View the complete list with 27 more genes
Specificity
9 %
Genes
100 %
HNPCC/Lynch Syndrome (MSH2) Sequencing and Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

MSH2
Specificity
100 %
Genes
25 %
Gastrointestinal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 16 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

SMAD4, BMPR1A, SDHD, STK11, CDH1, SDHB, SDHC, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
25 %
Genes
100 %
Lynch/Colorectal High Risk Panel.

By GeneDx in United States.

MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
58 %
Genes
100 %
Pancreatic Cancer Panel.

By GeneDx in United States.

XRCC2, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
25 %
Genes
100 %
OncoGeneDx Custom Panel.

By GeneDx in United States.

AXIN2, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 9 more genes
Specificity
14 %
Genes
100 %
Lynch Syndrome.

By Molecular Diagnostic Laboratory University of Alberta in Canada.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
CancerNext-Expanded.

By Ambry Genetics in United States.

HOXB13, GALNT12, DICER1, POT1, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1 , (...)

View the complete list with 44 more genes
Specificity
7 %
Genes
100 %
ColoNext.

By Ambry Genetics in United States.

POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
24 %
Genes
100 %
TumorNext-Lynch+ColoNext.

By Ambry Genetics in United States.

POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, NRAS, KRAS, BRAF, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
20 %
Genes
100 %
TumorNext-Lynch.

By Ambry Genetics in United States.

NRAS, KRAS, BRAF, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
50 %
Genes
100 %
GYNplus.

By Ambry Genetics in United States.

RAD51D, RAD51C, BRIP1, PALB2, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
31 %
Genes
100 %
MSH2 gene sequence and MSH2 and EPCAM deletion/duplication and MSH2 Inversion.

By Ambry Genetics in United States.

MSH2, EPCAM
Specificity
50 %
Genes
25 %
MSH2 Inversion Analysis.

By Ambry Genetics in United States.

MSH2
Specificity
100 %
Genes
25 %
MSH2 mutation analysis.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

MSH2
Specificity
100 %
Genes
25 %
MLH1, MSH2. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

MLH1, MSH2
Specificity
100 %
Genes
50 %
MSH2. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Colorectal and Gastrointestinal Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

POLE, POLD1, KIT, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
100 %
Hereditary High-Risk Colorectal Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

SMAD4, BMPR1A, STK11, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
34 %
Genes
100 %
CHOP Comprehensive Hereditary Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

DDB2, DIS3L2, MTAP, CEBPE, POLH, ARID5B, HMBS, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, DDX41, COL7A1, G6PC3, ITK, ELANE, EXT1, EXT2 , (...)

View the complete list with 86 more genes
Specificity
4 %
Genes
100 %
Hereditary nonpolyposis colorectal cancer (HNPCC, deletion/duplication analysis on MLH1, MSH2 and EPCAM genes).

By CGC Genetics in Portugal.

MLH1, MSH2, EPCAM
Specificity
67 %
Genes
50 %
Hereditary Non-polyposis Colorectal Cancer, HNPCC (sequence analysis of MSH2 gene).

By CGC Genetics in Portugal.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Non-polyposis Colorectal Cancer, HNPCC (sequence analysis of MLH1 and MSH2 genes).

By CGC Genetics in Portugal.

MLH1, MSH2
Specificity
100 %
Genes
50 %
Hereditary nonpolyposis colorectal cancer (HNPCC, NGS panel for 5 genes).

By CGC Genetics in Portugal.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Hereditary nonpolyposis colorectal cancer (HNPCC, NGS panel for 3 genes).

By CGC Genetics in Portugal.

MLH1, MSH6, MSH2
Specificity
100 %
Genes
75 %
Breast cancer (NGS panel for 18 genes).

By CGC Genetics in Portugal.

ERCC4, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
23 %
Genes
100 %
OncoRisk (NGS panel for 48 genes).

By CGC Genetics in Portugal.

EXT1, EXT2, FANCA, FANCB, NF1, RAD51C, CDC73, PRKAR1A, CEBPA, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN1C, CDKN2A, CDK4 , (...)

View the complete list with 28 more genes
Specificity
9 %
Genes
100 %
OncoRisk Plus (NGS panel for 89 genes).

By CGC Genetics in Portugal.

CEP57, DDB2, DIS3L2, XPC, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
5 %
Genes
100 %
Muir-Torre syndrome (sequence analysis of MLH1 and MSH2 genes).

By CGC Genetics in Portugal.

MLH1, MSH2
Specificity
100 %
Genes
50 %
Hereditary colon cancer (panel NGS of 21 genes).

By CGC Genetics in Portugal.

MSH3, MLH3, GALNT12, AXIN2, POLE, POLD1, TGFBR2, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
20 %
Genes
100 %
Hereditary nonpolyposis colorectal cancer (metilation analysis and deletions/duplications analysis of MLH1, MLH3, MSH2, MSH3, MSH6, PMS2 and MGMT by MS-MLPA).

By CGC Genetics in Portugal.

MSH3, MLH3, MLH1, MSH6, PMS2, MSH2
Specificity
67 %
Genes
100 %
Hereditary colon cancer (panel NGS of 21 genes).

By CGC Genetics in Portugal.

MSH3, MLH3, GALNT12, AXIN2, POLE, POLD1, TGFBR2, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
20 %
Genes
100 %
Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, RET, TP53 , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
100 %
Renal Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DIS3L2, DICER1, BAP1, SMARCB1, MITF, CDC73, CHEK2, MET, FLCN, SDHD, TSC1, TSC2, SDHA, SDHB, FH, SDHC, WT1, TP53, PTEN, MLH1 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
Hereditary Ovarian Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
24 %
Genes
100 %
Neurofibromatosis and related disorders Deletion / Duplication panel.

By Connective Tissue Gene Tests in United States.

SPRED1, NF1, NF2, MLH1, MSH6, MSH2
Specificity
50 %
Genes
75 %
Custom gene seqeuncing panel.

By Molecular Diagnostics Laboratory University Health Network in Canada.

LYZ, B2M, POT1, FGA, APOA1, BAP1, MITF, RYR1, CACNA1S, MET, FLCN, SDHD, CDKN2A, CDK4, TSC1, TSC2, SDHA, GSN, SDHB, FH , (...)

View the complete list with 10 more genes
Specificity
14 %
Genes
100 %
Hereditary Nonpolyposis Colon Cancer.

By MGZ Medical Genetics Center in Germany.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
MSH2-Related Lynch Syndrome.

By MGZ Medical Genetics Center in Germany.

MSH2
Specificity
100 %
Genes
25 %
Hereditary Cancer Syndromes - panels.

By MGZ Medical Genetics Center in Germany.

RNF43, CEP57, DDB2, DIS3L2, XPC, NTHL1, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, AXIN2, POLE, EGFR, GREM1 , (...)

View the complete list with 80 more genes
Specificity
4 %
Genes
100 %
Ovarian Cancer.

By MGZ Medical Genetics Center in Germany.

CEP57, BUB1B, DICER1, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, ATM, FANCC , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
Gastric Cancer.

By MGZ Medical Genetics Center in Germany.

PMS1, BMPR1A, CHEK2, STK11, CDH1, TP53, MLH1, MSH6, PMS2, MSH2
Specificity
40 %
Genes
100 %
Pancreatic Cancer.

By MGZ Medical Genetics Center in Germany.

PMS1, CHEK2, CDKN2A, STK11, PALB2, PTEN, MLH1, MSH6, PMS2, MSH2, BRCA2
Specificity
37 %
Genes
100 %
Colorectal cancer, hereditary nonpolyposis type 1.

By Centogene AG - the Rare Disease Company in Germany.

MSH2
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis type 1.

By Centogene AG - the Rare Disease Company in Germany.

MSH2
Specificity
100 %
Genes
25 %
CentoCancer panel.

By Centogene AG - the Rare Disease Company in Germany.

NTHL1, POLE, POLD1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, FLCN, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, BLM, FH , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
100 %
Muir-Torré syndrome.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

MLH1, MSH2
Specificity
100 %
Genes
50 %
Colorectal cancer, hereditary nonpolyposis Type 1.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

MSH2
Specificity
100 %
Genes
25 %
MSH2 ashkenazi mutation.

By Medical Genetics Institute Shaare Zedek Medical Center in Israel.

MSH2
Specificity
100 %
Genes
25 %
Disorders associated with malignancy Panel.

By CeGaT GmbH in Germany.

DDB2, POLH, XPC, RHBDF2, GTF2H5, CYLD, XPA, ERCC5, PDGFRB, FERMT1, ERCC8, AKT1, AXIN2, PIK3CA, ERCC4, NOP10, NHP2, WRAP53, CTC1, ERCC6 , (...)

View the complete list with 25 more genes
Specificity
9 %
Genes
100 %
Pancreatic cancer Panel.

By CeGaT GmbH in Germany.

PALLD, PRSS1, SPINK1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
24 %
Genes
100 %
Colon Cancer Panel.

By CeGaT GmbH in Germany.

AXIN1, RINT1, POLE, POLD1, SMAD4, BMPR1A, CHEK2, FLCN, STK11, NBN, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
22 %
Genes
100 %
Breast and Ovarian Cancer - extended Diagnostic Panel.

By CeGaT GmbH in Germany.

UIMC1, RINT1, MSH3, ABRAXAS1, XRCC2, FANCD2, SLX4, FANCE, FANCF, FANCG, FANCA, NF1, RAD51D, PMS1, BARD1, RAD51C, BRIP1, RAD50, CHEK2, SDHD , (...)

View the complete list with 21 more genes
Specificity
10 %
Genes
100 %
MSH2.

By Innovagenomics Innovagenomics S.L in Spain.

MSH2
Specificity
100 %
Genes
25 %
Lynch Syndrome, Colorectal Cancer, MSH2.

By GGA - Galil Genetic Analysis in Israel.

MSH2
Specificity
100 %
Genes
25 %
Cancer Predisposition.

By Asper Biogene Asper Biogene LLC in Estonia.

DDB2, DIS3L2, XPC, RHBDF2, CYLD, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
4 %
Genes
75 %
MLH1/MSH2 Deletion Duplication (MLPA).

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

MSH2
Specificity
100 %
Genes
25 %
Invitae Constitutional Mismatch Repair-Deficiency Panel.

By Invitae in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Invitae Sarcoma Panel.

By Invitae in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
16 %
Genes
100 %
Invitae Renal/Urinary Tract Cancers Panel.

By Invitae in United States.

DIS3L2, DICER1, BAP1, SMARCB1, SMARCA4, CDC73, GPC3, MET, FLCN, CDKN1C, TSC1, TSC2, SDHB, FH, SDHC, WT1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
100 %
Invitae Prostate Cancer Panel.

By Invitae in United States.

HOXB13, CHEK2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
34 %
Genes
100 %
Invitae Nervous System/Brain Cancer Panel.

By Invitae in United States.

DICER1, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, MEN1, RB1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
Invitae Pediatric Solid Tumors Panel.

By Invitae in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, SMARCE1, NF1, CDC73, PRKAR1A, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C, STK11, SUFU, NF2 , (...)

View the complete list with 28 more genes
Specificity
9 %
Genes
100 %
Invitae Colorectal Cancer Panel.

By Invitae in United States.

AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
23 %
Genes
100 %
Colorectal cancer, hereditary nonpolyposis- MLH1 and MSH2 genes deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MLH1, MSH2
Specificity
100 %
Genes
50 %
Colorectal cancer, hereditary nonpolyposis: MSH2 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MSH2
Specificity
100 %
Genes
25 %
COLON CANCER.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MSH3, PMS1, ENG, SMAD4, BMPR1A, FLCN, STK11, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
27 %
Genes
100 %
Lynch Syndrome: MSH2 Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MSH2
Specificity
100 %
Genes
25 %
Lynch Syndrome: MLH1, MSH2, MSH6, and PMS2 Full Gene Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Lynch Syndrome: MLH, MSH2, MSH6, and EPCAM Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MLH1, MSH6, MSH2, EPCAM
Specificity
75 %
Genes
75 %
Lynch Syndrome: MLH1, MSH2, MSH6, PMS2, and EPCAM Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MLH1, MSH6, MSH2, EPCAM
Specificity
75 %
Genes
75 %
High Risk Colorectal Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC
Specificity
27 %
Genes
100 %
Pancreatic Cancer: Sequencing Panel and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BAP1, PRSS1, SMAD4, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
27 %
Genes
100 %
High Risk Colorectal Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC
Specificity
20 %
Genes
75 %
Colon Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

EXO1, GALNT12, BUB1B, AXIN2, PMS1, SMAD4, BMPR1A, CHEK2, FLCN, CDKN2A, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
20 %
Genes
100 %
Hereditary Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC, AIP , (...)

View the complete list with 92 more genes
Specificity
4 %
Genes
100 %
Kidney Renal Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BAP1, MITF, MET, FLCN, SDHD, TSC1, TSC2, SDHA, SDHB, FH, SDHC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, VHL
Specificity
22 %
Genes
100 %
Renal/Kidney NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BAP1, SMARCB1, MITF, CDC73, MET, FLCN, SDHD, TSC1, TSC2, SDHA, SDHB, FH, SDHC, WT1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 2 more genes
Specificity
19 %
Genes
100 %
Colorectal Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

AXIN2, POLE, POLD1, SMAD4, BMPR1A, CHEK2, STK11, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
25 %
Genes
100 %
Prostate Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

CHEK2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
40 %
Genes
100 %
Hematologic Malignancy Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
25 %
Genes
100 %
Comprehensive Cancer Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, DIS3L2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC , (...)

View the complete list with 104 more genes
Specificity
4 %
Genes
100 %
Gastric Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

PDGFRA, KIT, NF1, SMAD4, BMPR1A, STK11, CDH1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
29 %
Genes
100 %
Endometrial Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

POLD1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
40 %
Genes
100 %
Lynch Syndrome, MSH2 Sequencing and Deletion/Duplication.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

MSH2
Specificity
100 %
Genes
25 %
GIvantage Hereditary Colon Cancer Panel.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

SMAD4, BMPR1A, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
31 %
Genes
100 %
Hemato-oncology chromosomal microarray.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center in United States.

NUTM2B, NUTM2A, SSX2, MALAT1, ETV4, TFEB, SSX4, NR4A3, MSI2, CREB3L2, TFE3, FOXO1, ETV1, ACSL3, RABEP1, SSX1, SS18, POU5F1, HEY1, JUN , (...)

View the complete list with 72 more genes
Specificity
3 %
Genes
50 %
Hereditary Pediatric Cancer Panel.

By Blueprint Genetics in Finland.

REST, DIS3L2, BUB1B, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, EZH2, RRAS, RASA2, NSUN2, LZTR1, NF1, CDC73, PRKAR1A, PRF1, CEBPA, PAX5 , (...)

View the complete list with 51 more genes
Specificity
6 %
Genes
100 %
Hereditary Renal Cancer Panel.

By Blueprint Genetics in Finland.

REST, DIS3L2, DICER1, BAP1, SMARCB1, SMARCA4, CDC73, GPC3, MET, FLCN, SDHD, CDKN1C, TSC1, TSC2, SDHB, FH, SDHC, WT1, TP53, PTEN , (...)

View the complete list with 6 more genes
Specificity
16 %
Genes
100 %
Hereditary Cancer High Risk Panel.

By Blueprint Genetics in Finland.

POLE, POLD1, BAP1, RAD51D, RAD51C, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 8 more genes
Specificity
15 %
Genes
100 %
COLOTRUE™.

By Pathway Genomics in United States.

MDM2, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
27 %
Genes
100 %
Focus::HERSite® NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
25 %
Genes
100 %
Breast Cancer Panel.

By ApolloGen, Inc. in United States.

RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, MSH2, BRCA2, BRCA1
Specificity
20 %
Genes
75 %
Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch Syndrome.

By GeneKor MSA in Greece.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Lynch Syndrome.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Hereditary Cancer.

By Color Genomics, Inc. Color Genomics, Inc. in United States.

POLE, GREM1, POLD1, BAP1, MITF, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN , (...)

View the complete list with 9 more genes
Specificity
14 %
Genes
100 %
Otogenetics Hereditary Cancers.

By Otogenetics in United States.

PALLD, RAD51, NF1, NTRK1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2, PTCH1, NBN , (...)

View the complete list with 19 more genes
Specificity
11 %
Genes
100 %
COLORECTAL CANCER, NONPOLYPOSIC (LYNCH SYNDROME).

By Laboratorio de Genetica Clinica SL in Spain.

MLH3, MLH1, MSH6, PMS2, MSH2
Specificity
80 %
Genes
100 %
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 90 Genes.

By Reference Laboratory Genetics in Spain.

CEP57, DDB2, DIS3L2, XPC, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL , (...)

View the complete list with 70 more genes
Specificity
5 %
Genes
100 %
Hereditary Non-Polyposis Colon Cancer , Panel Massive Sequencing (NGS) MLH1, MSH2, MSH6, PMS2 Genes.

By Reference Laboratory Genetics in Spain.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Familial Pancreatic Cancer , Panel Massive Sequencing (NGS) 16 Genes.

By Reference Laboratory Genetics in Spain.

MLH3, TGFBR2, SMAD4, CDKN2A, STK11, PALB2, KRAS, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
25 %
Genes
100 %
Hereditary Gastric Cancer , Panel Massive Sequencing (NGS) 8 Genes.

By Reference Laboratory Genetics in Spain.

SMAD4, BMPR1A, CDH1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
50 %
Genes
100 %
Lynch syndrome/HNPCC.

By Labor Dr. Wisplinghoff in Germany.

MLH1, MSH6, PMS2, MSH2
Specificity
100 %
Genes
100 %
Phosphorus Leukemia Panel.

By Phosphorus Diagnostics LLC in United States.

TERT, TERC, DKC1, NF1, CEBPA, GATA2, NBN, ATM, TINF2, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
23 %
Genes
100 %
Phosphorus Ovarian/Uterine Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, SMARCA4, RAD51D, RAD51C, BRIP1, PALB2, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
27 %
Genes
100 %
Phosphorus Brain and Nervous System Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, MAX, SDHD, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, SDHA, MEN1 , (...)

View the complete list with 15 more genes
Specificity
12 %
Genes
100 %
Phosphorus Pancreatic Cancer including Chronic Pancreatitis Genes Panel.

By Phosphorus Diagnostics LLC in United States.

CTRC, PRSS1, SPINK1, CASR, NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, CFTR, MEN1, TP53, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
100 %
Phosphorus Pancreatic Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
20 %
Genes
100 %
Phosphorus Renal/Urinary Tract Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, DICER1, BAP1, SMARCB1, SMARCA4, MITF, CDC73, GPC3, MET, FLCN, SDHD, CDKN1C, TSC1, TSC2, SDHA, SDHB, FH, SDHC, WT1, TP53 , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
100 %
Phosphorus Pan-Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AIP, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, XRCC2, KIT, SMARCB1, SMARCA4, SMARCE1, TERT , (...)

View the complete list with 63 more genes
Specificity
5 %
Genes
100 %
Phosphorus Common/High Risk Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

POLE, GREM1, POLD1, BAP1, MITF, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM , (...)

View the complete list with 12 more genes
Specificity
13 %
Genes
100 %
Phosphorus Pediatric Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, TERT, TERC, EZH2, NF1, CDC73, PRKAR1A, CEBPA, GATA2, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C , (...)

View the complete list with 33 more genes
Specificity
8 %
Genes
100 %
Renal Cancer: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, BAP1, SMARCB1, CDC73, GPC3, MET, FLCN, SDHD, CDKN1C, PALB2, TSC1, TSC2, SDHB, FH, SDHC, WT1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
100 %
Renal Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, BAP1, SMARCB1, CDC73, GPC3, MET, FLCN, SDHD, CDKN1C, PALB2, TSC1, TSC2, SDHB, FH, SDHC, WT1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 2 more genes
Specificity
14 %
Genes
75 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
20 %
Genes
75 %
CEN4GEN Colorectal cancer: Extended Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MIER3, TCERG1, ATP6V0D2, ACVR1B, PTPN12, GALNT17, MAP2K4, MAP7, FZD3, MYO1B, CDC27, TCF7L2, BAX, DCC, ERBB2, MSH3, GPC6, PIK3R1, AKT1, FBXW7 , (...)

View the complete list with 18 more genes
Specificity
8 %
Genes
75 %
CEN4GEN Ovarian cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

KREMEN1, USP16, MAS1L, CSMD3, FAT3, GABRA6, CCNE1, PPP2R1A, ERBB2, CDK12, PIK3R1, AKT1, CBLC, PDGFRA, EGFR, PIK3CA, KIT, ARID1A, CTNNB1, NF1 , (...)

View the complete list with 12 more genes
Specificity
7 %
Genes
50 %
High Risk Colorectal Cancer: Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC
Specificity
27 %
Genes
100 %
Lynch Syndrome: MLH1, MSH2, MSH6, PMS2, and EPCAM Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
80 %
Genes
100 %
Lynch Syndrome: MSH2 Gene Deletion/Duplication.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MSH2
Specificity
100 %
Genes
25 %
Pancreatic Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PRSS1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
22 %
Genes
75 %
Pancreatic Cancer: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PRSS1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL, BRCA2, BRCA1
Specificity
29 %
Genes
100 %
MSH6 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Deletion/Duplication.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Sequencing and Deletion/Duplication.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Comprehensive Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Deletion/Duplication Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6-Related Lynch syndrome.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6-Related Lynch Syndrome.

By Molecular Genetics Rabin Medical Center in Israel.

MSH6
Specificity
100 %
Genes
25 %
MSH6.

By Institute for Human Genetics University Clinic Freiburg in Germany.

MSH6
Specificity
100 %
Genes
25 %
HNPCC/Lynch Syndrome (MSH6) Sequencing and Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 mutation analysis.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

MSH6
Specificity
100 %
Genes
25 %
Hereditary nonpolyposis colorectal cancer (HNPCC, sequence analysis of MSH6 gene).

By CGC Genetics in Portugal.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome via MSH6 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MSH6
Specificity
100 %
Genes
25 %
Test for MSH6-Related Lynch Syndrome.

By All Wales Genetics Laboratory Institute of Medical Genetics in United Kingdom.

MSH6
Specificity
100 %
Genes
25 %
MSH6-Related Lynch Syndrome.

By ProntoLab - MLPA Lab Pronto Diagnostics Ltd. in Israel.

MSH6
Specificity
100 %
Genes
25 %
MSH6-Related Lynch Syndrome.

By Clinical Genomics Maastricht University Medical Centre in Netherlands.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Gene Sequencing.

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

MSH6
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis, 5.

By Praxis fuer Humangenetik Wien in Austria.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome.

By Department of Clinical Genetics St. Elisabeth Cancer Institute in Slovakia.

MSH6
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis, 5.

By MedGene in Slovakia.

MSH6
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis: MSH 6 gene deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome: MSH6 Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome: MSH6 Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Full Gene Sequencing.

By Fulgent Genetics Fulgent Genetics in United States.

MSH6
Specificity
100 %
Genes
25 %
Hereditary nonpolyposis colorectal cancer type V.

By Bioarray in Spain.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

MSH6
Specificity
100 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer, Deletions-Duplications (MLPA) MSH6 Gene.

By Reference Laboratory Genetics in Spain.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 full gene sequencing.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

MSH6
Specificity
100 %
Genes
25 %
Hereditary Nonpolyposis Colorectal Cancer (HNPCC): MSH6 (Known Mutation).

By Molecular Diagnostic Laboratory LabCorp in United States.

MSH6
Specificity
100 %
Genes
25 %
MSH6 - Related Lynch Syndrome.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

MSH6
Specificity
100 %
Genes
25 %
MutS, E. COLI, HOMOLOG OF, 6; MSH6.

By Human Genetics Ruhr University in Germany.

MSH6
Specificity
100 %
Genes
25 %
MSH6. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

MSH6
Specificity
100 %
Genes
25 %
MSH6. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

MSH6
Specificity
100 %
Genes
25 %
Hereditary nonpolyposis colorectal cancer, type 5 (HNPCC, deletion/duplication analysis on MSH6 gene).

By CGC Genetics in Portugal.

MSH6
Specificity
100 %
Genes
25 %
MSH6-Related Lynch Syndrome.

By MGZ Medical Genetics Center in Germany.

MSH6
Specificity
100 %
Genes
25 %
Breast ovarian cancer panel.

By Centogene AG - the Rare Disease Company in Germany.

RAD51, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MSH6
Specificity
8 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis type 5.

By Centogene AG - the Rare Disease Company in Germany.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome, Colorectal Cancer, MSH6.

By GGA - Galil Genetic Analysis in Israel.

MSH6
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis: MSH 6 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MSH6
Specificity
100 %
Genes
25 %
MSH6.

By Fulgent Genetics Fulgent Genetics in United States.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome, MSH6 Sequencing and Deletion/Duplication.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

MSH6
Specificity
100 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer, Sequencing MSH6 Gene.

By Reference Laboratory Genetics in Spain.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome: MSH6 Gene Sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MSH6
Specificity
100 %
Genes
25 %
Lynch Syndrome: MSH6 Gene Deletion/Duplication.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MSH6
Specificity
100 %
Genes
25 %
MLH1 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Deletion/Duplication.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Sequencing and Deletion/Duplication.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Promoter Hypermethylation.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Deletion/Duplication Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1-Related Lynch syndrome.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Related Lynch Syndrome.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

MLH1
Specificity
100 %
Genes
25 %
MutL, E. COLI, HOMOLOG OF, 1; MLH1.

By Human Genetics Ruhr University in Germany.

MLH1
Specificity
100 %
Genes
25 %
HNPCC/Lynch Syndrome (MLH1) Sequencing and Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1-Related Lynch Syndrome.

By Laboratory of Genetics HUSLAB in Finland.

MLH1
Specificity
100 %
Genes
25 %
MLH1 promoter methylation.

By Molecular Diagnostics Laboratory University Health Network in Canada.

MLH1
Specificity
100 %
Genes
25 %
Cancer Hotspot Panel.

By Centogene AG - the Rare Disease Company in Germany.

MYCL, ROS1, RPTOR, KIF5B, GNAI2, GNA13, EML4, BRD4, ARAF, NFE2L2, GNG2, KEAP1, NRG1, CCNE1, CD74, RICTOR, ERBB4, MYC, BCL6, SMO , (...)

View the complete list with 68 more genes
Specificity
2 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis type 2.

By Centogene AG - the Rare Disease Company in Germany.

MLH1
Specificity
100 %
Genes
25 %
MLH1.

By Innovagenomics Innovagenomics S.L in Spain.

MLH1
Specificity
100 %
Genes
25 %
Lynch dyndrome, Colorectal Cancer, MLH1.

By GGA - Galil Genetic Analysis in Israel.

MLH1
Specificity
100 %
Genes
25 %
MLH1-Related Lynch Syndrome.

By ProntoLab - MLPA Lab Pronto Diagnostics Ltd. in Israel.

MLH1
Specificity
100 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer (HNPCC),MLH1 sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

MLH1
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis, 2.

By Praxis fuer Humangenetik Wien in Austria.

MLH1
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis: MLH1 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MLH1
Specificity
100 %
Genes
25 %
Lynch Syndrome, MLH1 Sequencing and Deletion/Duplication.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

MLH1
Specificity
100 %
Genes
25 %
Lynch syndrome.

By Bioarray in Spain.

MLH1
Specificity
100 %
Genes
25 %
Solid Tumor Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

BCL2L1, H3F3A, KLF4, TRAF7, PIK3C2B, HIST1H3B, JAK1, MCL1, PBRM1, DAXX, CDKN1A, MYB, MYBL1, RAD54B, ESR2, ESR1, KMT2C, FGFR4, ROS1, NFE2L2 , (...)

View the complete list with 102 more genes
Specificity
1 %
Genes
25 %
Cancer Hotspot Analysis.

By Advanced Technology Laboratory Spectrum Health in United States.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 30 more genes
Specificity
2 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer, Sequencing MLH1 Gene.

By Reference Laboratory Genetics in Spain.

MLH1
Specificity
100 %
Genes
25 %
152 Integrated Advantage NGS Solid Tumor Panel.

By Integrated Molecular Diagnostics Pathology, Inc. in United States.

AURKA, TOP1, ABCC1, SLC29A1, STK11IP, SYK, SULT1A1, XRCC1, TOP2A, TOP2B, PLK1, JAK1, JUN, IKBKE, BCL2L2, AURKB, MDM4, MAP2K4, EMSY, CHEK1 , (...)

View the complete list with 132 more genes
Specificity
1 %
Genes
25 %
CEN4GEN Lung cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ADGRB3, LRP1B, EPHA5, MUC16, GRM8, PIK3CG, ROS1, NFE2L2, KEAP1, ERBB4, MYC, ERBB2, MDM2, RUNX1T1, AKT1, FBXW7, PDGFRA, EGFR, RARB, PIK3CA , (...)

View the complete list with 24 more genes
Specificity
3 %
Genes
25 %
CEN4GEN Comprehensive targeted oncogene tumor mutation screen (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
25 %
Lynch Syndrome: MLH1 Gene Deletion/Duplication.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 full gene sequencing.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Promoter Methylation Studies.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories in United States.

MLH1
Specificity
100 %
Genes
25 %
Hereditary Nonpolyposis Colorectal Cancer (HNPCC): MLH1 (Known Mutation).

By Molecular Diagnostic Laboratory LabCorp in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Comprehensive Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1.

By Institute for Human Genetics University Clinic Freiburg in Germany.

MLH1
Specificity
100 %
Genes
25 %
Microsatellite Instability (MSI) Analysis.

By Ambry Genetics in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Promoter Hypermethylation.

By Ambry Genetics in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 mutation analysis.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

MLH1
Specificity
100 %
Genes
25 %
MLH1. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

MLH1
Specificity
100 %
Genes
25 %
Hereditary Non-polyposis Colorectal Cancer, HNPCC (sequence analysis of MLH1 gene).

By CGC Genetics in Portugal.

MLH1
Specificity
100 %
Genes
25 %
Methylation analysis of the MLH1 gene promotor by ms-MLPA.

By CGC Genetics in Portugal.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Related Lynch Syndrome.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

MLH1
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis, type 2.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

MLH1
Specificity
100 %
Genes
25 %
Lynch Syndrome via MLH1 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1-Related Lynch Syndrome.

By MGZ Medical Genetics Center in Germany.

MLH1
Specificity
100 %
Genes
25 %
MLH1-Related Lynch Syndrome.

By Bioscientia GmbH Center for Human Genetics in Germany.

MLH1
Specificity
100 %
Genes
25 %
Solid Tumor Panel.

By Centogene AG - the Rare Disease Company in Germany.

KMT2C, FGFR4, NTRK3, ROS1, AXL, SMO, ERBB2, DDR2, KDR, PDGFRB, PIK3R1, AKT1, GNA11, IDH1, PDGFRA, ABL1, JAK2, EGFR, GNAQ, PIK3CA , (...)

View the complete list with 42 more genes
Specificity
2 %
Genes
25 %
Test for MLH1-Related Lynch Syndrome.

By All Wales Genetics Laboratory Institute of Medical Genetics in United Kingdom.

MLH1
Specificity
100 %
Genes
25 %
MLH1-Related Lynch Syndrome.

By Clinical Genomics Maastricht University Medical Centre in Netherlands.

MLH1
Specificity
100 %
Genes
25 %
MLH1/MSH2 Deletion Duplication (MLPA).

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

MLH1
Specificity
100 %
Genes
25 %
MLH1 gene sequencing.

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

MLH1
Specificity
100 %
Genes
25 %
Lynch Syndrome.

By Department of Clinical Genetics St. Elisabeth Cancer Institute in Slovakia.

MLH1
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis, 2.

By MedGene in Slovakia.

MLH1
Specificity
100 %
Genes
25 %
Lynch Syndrome: MLH1 Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MLH1
Specificity
100 %
Genes
25 %
Lynch Syndrome: MLH1 Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1 Full Gene Sequencing.

By Fulgent Genetics Fulgent Genetics in United States.

MLH1
Specificity
100 %
Genes
25 %
MLH1.

By Fulgent Genetics Fulgent Genetics in United States.

MLH1
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis, type 2.

By Bioarray in Spain.

MLH1
Specificity
100 %
Genes
25 %
Lynch syndrome.

By Bioarray in Spain.

MLH1
Specificity
100 %
Genes
25 %
Genitourinary Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

PBRM1, CDKN1A, KMT2C, RXRA, ERBB2, PIK3R1, AKT1, AKT3, FBXW7, STAG2, EGFR, AKT2, PIK3CA, BAP1, ERBB3, TERT, KDM6A, MTOR, MED12, ERCC2 , (...)

View the complete list with 24 more genes
Specificity
3 %
Genes
25 %
Gynecologic Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

ERBB4, PPP2R1A, FAT1, SMO, ERBB2, CDK12, CCND1, KDR, PIK3R1, AKT1, AKT3, PIK3R2, POLE, FBXW7, ABL1, EGFR, AKT2, POLD1, PIK3CA, JAK3 , (...)

View the complete list with 30 more genes
Specificity
2 %
Genes
25 %
Guardant360.

By Guardant Health in United States.

MAPK3, RHOA, RHEB, MAPK1, ESR1, NTRK3, ROS1, ARAF, NFE2L2, CCNE1, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, CCND2, AKT1, GNA11, FBXW7 , (...)

View the complete list with 53 more genes
Specificity
2 %
Genes
25 %
MLH1 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

MLH1
Specificity
100 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer, Deletions-Duplications (MLPA) MLH1 Gene.

By Reference Laboratory Genetics in Spain.

MLH1
Specificity
100 %
Genes
25 %
Lynch Syndrome: MLH1 Gene Sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MLH1
Specificity
100 %
Genes
25 %
PMS2 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 sequence analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

PMS2
Specificity
100 %
Genes
25 %
Hereditary Nonpolyposis Colorectal Cander (HNPCC): PMS2 (Known Mutation).

By Molecular Diagnostic Laboratory LabCorp in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 Deletion/Duplication Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2.

By Institute for Human Genetics University Clinic Freiburg in Germany.

PMS2
Specificity
100 %
Genes
25 %
PMS2.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

PMS2
Specificity
100 %
Genes
25 %
HNPCC/Lynch Syndrome (PMS2) Sequencing and Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 mutation analysis.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

PMS2
Specificity
100 %
Genes
25 %
Hereditary nonpolyposis colorectal cancer (HNPCC, deletion/duplication analysis on PMS2 gene).

By CGC Genetics in Portugal.

PMS2
Specificity
100 %
Genes
25 %
Hereditary nonpolyposis colorectal cancer (HNPCC, sequence analysis of PMS2 gene).

By CGC Genetics in Portugal.

PMS2
Specificity
100 %
Genes
25 %
PMS2-Related Lynch Syndrome.

By MGZ Medical Genetics Center in Germany.

PMS2
Specificity
100 %
Genes
25 %
Colorectal cancer, hereditary nonpolyposis type 4.

By Centogene AG - the Rare Disease Company in Germany.

PMS2
Specificity
100 %
Genes
25 %
Syndromes with immunodeficiency Panel.

By CeGaT GmbH in Germany.

SP110, RPSA, FCGR3A, ZBTB24, MCM4, SPINK5, RNF168, DNMT3B, TYK2, SMARCAL1, PDGFRA, NOD2, NHP2, CFH, FGF10, ADAR, DOCK8, TERT, TERC, DKC1 , (...)

View the complete list with 18 more genes
Specificity
3 %
Genes
25 %
Lynch Syndrome, Colorectal Cancer, PMS2.

By GGA - Galil Genetic Analysis in Israel.

PMS2
Specificity
100 %
Genes
25 %
Invitae Primary Immunodeficiency Panel.

By Invitae in United States.

IRF7, RORC, DCLRE1B, DOCK2, MAP3K14, NFAT5, IL17RC, TAPBP, TAP2, TNFRSF4, RHOH, FPR1, SP110, TNFSF12, IKBKB, LCK, CTPS1, ZBTB24, ADAM17, BCL10 , (...)

View the complete list with 187 more genes
Specificity
1 %
Genes
25 %
Lynch Syndrome: PMS2 Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2.

By Fulgent Genetics Fulgent Genetics in United States.

PMS2
Specificity
100 %
Genes
25 %
Primary Immunodeficiency Panel.

By Blueprint Genetics in Finland.

BCL11B, OTULIN, IRF2BP2, RASGRP1, CARMIL2, ZNF341, TFRC, POLE2, HYOU1, JAK1, ARPC1B, BACH2, LAT, MRTFA, MSN, GINS1, CD59, ADAM17, BCL10, IRF8 , (...)

View the complete list with 255 more genes
Specificity
1 %
Genes
25 %
Severe Combined Immunodeficiency Panel.

By Blueprint Genetics in Finland.

BCL11B, TFRC, POLE2, LAT, MSN, NSMCE3, MAP3K14, TAPBP, TAP2, TNFRSF4, RHOH, SP110, IKBKB, LCK, IRF8, CD247, CD8A, STAT2, CORO1A, CD3G , (...)

View the complete list with 59 more genes
Specificity
2 %
Genes
25 %
Mismatch repair cancer syndrome.

By Bioarray in Spain.

PMS2
Specificity
100 %
Genes
25 %
Lynch syndrome type IV.

By Bioarray in Spain.

PMS2
Specificity
100 %
Genes
25 %
PMS2 Comprehensive Analysis.

By Molecular Diagnostic Laboratory LabCorp in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

PMS2
Specificity
100 %
Genes
25 %
Lynch Syndrome via PMS2 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

PMS2
Specificity
100 %
Genes
25 %
Invitae Syndromic Combined Immunodeficiency (CID) Panel.

By Invitae in United States.

DCLRE1B, SP110, ZBTB24, SPINK5, DNMT3B, PGM3, ACD, TTC7A, SMARCAL1, EPG5, WIPF1, NFKBIA, FOXN1, ORAI1, STAT5B, POLE, STIM1, NOP10, NHP2, CTC1 , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
Colorectal cancer, Hereditary nonpolyposis: PMS2 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

PMS2
Specificity
100 %
Genes
25 %
PMS2 Full Gene Sequencing.

By Fulgent Genetics Fulgent Genetics in United States.

PMS2
Specificity
100 %
Genes
25 %
LYNCH SYNDROME, PMS2 SEQUENCING AND DELETION/DUPLICATION.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

PMS2
Specificity
100 %
Genes
25 %
PMS2 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

PMS2
Specificity
100 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer, Sequencing PMS2 Gene.

By Reference Laboratory Genetics in Spain.

PMS2
Specificity
100 %
Genes
25 %
Hereditary Non-Polyposis Colon Cancer , Deletions-Duplications (MLPA) PMS2 Gene.

By Reference Laboratory Genetics in Spain.

PMS2
Specificity
100 %
Genes
25 %
Lynch Syndrome: PMS2 Gene Sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PMS2
Specificity
100 %
Genes
25 %

Alternate names

Mismatch Repair Cancer Syndrome; Mmrcs Is also known as constitutional mismatch repair deficiency syndrome;cmmrds, mismatch repair deficiency, mmr deficiency, childhood cancer syndrome, brain tumor-polyposis syndrome 1;btps1, btp1 syndrome, turcot syndrome;cmmr-d syndrome.



If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PROGESTERONE RESISTANCE

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more